A magnetic resonance imaging (MRI) contrast agent is able to directly target tumours, potentially allowing improved diagnosis. Researchers at the University of Pennsylvania’s School of Engineering and Applied Science have designed glycol chitosan-coated iron-oxide nanoparticles that are attracted to the acidic environments in which tumours generally thrive.
